Cyclin D1 overexpression in malignant lymphomas

Pathology International

Volumn 47, Issue 7, 1997, Pages 421-429

  Nakamura, Shigeo ^a   Yatabe, Yasushi ^a   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CCND1; Cyclin D1; Immunohistochemistry; Mantle cell lymphoma; Monoclonal antibody; PRAD1

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ADULT; AGED; B CELL LYMPHOMA; CANCER CYTODIAGNOSIS; CELL CYCLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

EID: 0030955867     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04519.x     Document Type: Review

References (75)

1. Hunter T. Cooperations between oncogenes. Cell 1991; 64: 249-270.
2. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994; 372; 143-149.
3. Gaidano G, Dala-Favera R. Molecular biology of lymphomas. In: De Vita VT, Hellman S, Rosenberg SA, eds. Principles and Practice of Oncology, 5th edn. JB Lippincott, Philadelphia, 1997 (in press).
4. Banks PM, Chan J, Cleary ML et al. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am. J. Surg. Pathol. 1992; 16: 637-640.
5. Jaffe ES, Raffeld M, Medeiros LJ, Stetler-Stevenson M. An overview of the classification of non-Hodgkin's lymphomas: An integration of morphological and phenotypical concepts. Cancer Res. 1992; 52 (Suppl.): S5447-5452.
6. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
7. Weisenburger DD, Armitage JO. Mantle cell lymphoma: An entity comes of age. Blood 1996; 87: 4483-4494.
8. Berard CW. Reticuloendothelial system: An overview of neoplasia. In: Rebuck JW, Berard CW, Abell MR, eds. The Reticuloendothelial System. Williams & Wilkins, Baltimore, 1975; 301-317.
9. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 1982; 49: 1429-1438.
10. Nanba K, Jaffe ES, Braylan RC, Soban EJ, Berard CW. Alkaline phosphatase-positive malignant lymphoma: A subtype of B-cell lymphomas. Am. J. Clin. Pathol. 1977; 68: 535-542.
11. Lennert K, Feller AC, eds. Histopathology of Non-Hodgkin's Lymphoma. Springer Verlag, Berlin, 1992.
12. Tsujimoto Y, Yunis J, Onorato-Showe L, Elikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403-1406.
13. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 1987; 69: 1617-1621.
14. Meeker TC, Grimaldi JC, O'Rourke R, Louie E, Juliusson G, Einhorn S. Blood 1990; 74: 1801-1806.
15. Medeiros LJ, van Krieken JH, Jaffe ES, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990; 76: 2086-2090.
16. Rimokh R, Berger F, Cornillet P et al. Break in the BCL-1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chromosomes Cancer 1990; 2: 223-226.
17. Raffeld M, Jaffe ES. BCL-1, t(11;14), and mantle cell-derived lymphomas. Blood 1990; 76: 2086-2090.
18. Leroux D, Le Marc'Hadour F, Gressin R et al. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/ intermediate lymphocytic lymphomas? Br. J. Haematol. 1991; 77: 346-353.
19. Vandenberghe E, de Wolf-Peeters C, Wlodarska I et al. Chromosome 11q rearrangements in B non-Hodgkin's lymphoma. Br. J. Haematol. 1992; 81: 212-217.
20. Motokura T, Bloom T, Kim HG et al. A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 1991; 350: 512-515.
21. Yatabe Y, Nakamura S, Seto M et al. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. Am. J. Surg. Pathol. 1996; 20: 1110-1122.
22. Marx J. How cells cycle towards cancer. Science 1994; 263: 319-321.
23. Arnold A, Kim HG, Gaz RD et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest. 1989; 83: 2034-2040.
24. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991; 6: 449-453.
25. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991; 65: 691-699.
26. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
27. Withers DA, Harvey RC, Faust JR, Melnyk O, Carey K, Meeker TC. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol. 1991; 11: 4846-4853.
28. Rosenberg CL, Wong E, Petty EM et al. PRAD1, a candidate BCL-1 oncogene: Mapping and expression in centrocytic lymphoma. Proc. Natl Acad. Sci. USA 1991; 88: 9638-9642.
29. Seto M, Yamamoto K, Iida S et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with the t(11;14) (q13;q23) translocation. Oncogene 1992; 7: 1401-1406.
30. Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G. Cyclin D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 1993; 8: 1049-1054.
31. Komatsu H, Yoshida K, Seto M et al. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation. Br. J. Haematol. 1993; 85: 427-429.
32. Komatsu H, Iida S, Yamamoto K et al. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 1994; 84: 1226-1231.
33. Chary-Reddy S, Prasad VS, Ahuja YR. Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency. Cancer Lett. 1994; 86: 111-117.
34. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Characterization of chromosome 11 translocation breakpoint at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res. 1992; 52 (Suppl.): S5541-5544.
35. Rimokh R, Berger F, Delsol G et al. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993; 81: 3063-3067.
36. de Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuuring E, van Krieken JHJM. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: Rearrangements of the cyclin D1 gene. Cancer Res. 1993; 53: 4148-4152.
37. Hayashi T, Ohno H, Yamabe H et al. Clinical aspects of B-cell malignancy involving the BCL-1/PRAD1 locus. Int. J. Hematol. 1994; 59: 281-296.
38. Bosch F, Jares P, Campo E et al. PRAD1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726-2732.
39. Kuroda H, Komatsu H, Nakamura S et al. The nuclear staining pattern observed with monoclonal antibody against PRAD1/ cyclin D1 correlates with the mRNA overexpression in mantle cell-derived lymphoma. Jpn. J. Cancer Res. 1995; 86: 890-898.
40. Rimokh R, Berger F, Bastard C et al. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 1994; 83: 3689-3696.
41. Oka K, Ohno T, Kita K et al. PRAD1 gene overexpression in mantle cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br. J. Haematol. 1994; 86: 786-791.
42. de Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, Kluin PM, Schuuring E. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995; 10: 1833-1840.
43. Williams ME, Swerdlow SH, Meeker TC. Chromosome t(11;14) (q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 1993; 7: 1437-1440.
44. Rimokh R, Berger F, Delsol G et al. Detection of the chromosomal translocation in t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83: 1871-1875.
45. Luthra R, Hai S, Pugh WC. Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn. Mol. Pathol. 1995; 4: 4-7.
46. Segal GH, Masih AS, Fox AC, Jorgensen T, Scott M, Braylan RC. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood 1995; 85: 1570-1579.
47. Zucca E, Soldati G, Schlegelberger B et al. Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br. J. Haematol. 1995; 89: 665-668.
48. Takashima T, Ito M, Ueda Y et al. Detection of 14q32.33 translocation and t(11;14) in interphase nuclei of chronic B-cell leukemia/lymphomas by in situ hybridization (in press).
49. Müller R, Mumberg D, Lucibello F. Biochim. Biophys. Acta 1993; 1155: 151-179.
50. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
51. Lukas J, Jadayel D, Bartikova J et al. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 1994; 9: 2159-2167.
52. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomatogenesis with the myc gene. EMBO J. 1994; 13: 2124-2130.
53. Lovec H, Grzeschiezek A, Kowalski MB, MöröyT. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994; 13: 3487-3495.
54. Banno S, Yoshikawa K, Nakamura S et al. Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. Jpn. J. Cancer Res. 1994; 85: 918-926.
55. Nakamura S, Seto M, Banno S et al. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. 1994; 85: 1270-1279.
56. Delmer A, Ajchenbaum-Cymbalista F, Tang R et al. Overexpression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br. J. Haematol. 1995; 89: 798-804.
57. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol. 1994; 145: 86-96.
58. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphoma: Detection by immunohistochemistry. Am. J. Clin. Pathol. 1995; 103: 756-760.
59. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86: 2715-2723.
60. Gillett C, Fantl V, Smith R et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994; 54: 1812-1817.
61. Harris NL, Bhan AK. Mantle-zone lymphoma: A pattern produced by lymphomas of more than one cell type. Am. J. Surg. Pathol. 1985; 9: 872-882.
62. van den Oord JJ, de Wolf-Peeters C, Pulford KAP, Mason DY, Desmet VJ. Mantle zone lymphoma: Immuno- and enzymehistochemical studies on the cell of origin. Am. J. Surg. Pathol. 1986; 10: 780-788.
63. Weisenburger DD, Linder J, Daley DT, Armitage JO. Intermediate lymphocytic lymphoma: An immunohistologic study with comparison to other lymphocytic lymphomas. Hum. Pathol. 1987; 18: 781-790.
64. Jaffe ES, Bookman MA, Longo DL. Lymphocytic lymphoma of intermediate differentiation - mantle zone lymphoma: A distinct subtype of B-cell lymphoma. Hum. Pathol. 1987; 18: 877-880.
65. Strickler JG, Medeiros J, Copenhaver CM, Weiss LM, Warnke RA. Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Hum. Pathol. 1988; 19: 550-554.
66. Lardelli P, Bookman M, Sundeen J, Longo D, Jaffe E. Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlation. Am. J. Surg. Pathol. 1990; 14: 752-763.
67. Abe M, Ono N, Tominaga K et al. Histogenesis of diffuse small cleaved cell lymphoma: An immunohistochemical and molecular genetic (bcl-2 gene) study with comparison to follicular small cleaved cell lymphoma and mantle zone lymphoma. Cancer 1992; 70: 821-829.
68. Takeshita M, Masuda Y, Sumiyoshi Y et al. Clinicopathologic, enzyme and histochemical studies of centrocytic (mantle cell) lymphoma: Comparison with other types of low grade B cell lymphoma based on the updated Kiel classification. Acta Pathol. Jpn. 1993; 43: 244-252.
69. Swerdlow SH, Saboorian MH, Pelstring RJ, Williams ME. Centrocytic lymphoma: A morphometric study with comparison to other small cleaved follicular center cell lymphomas and genotypic correlates. Am. J. Pathol. 1993; 142: 329-337.
70. Weisenburger DD, Chan WC. Lymphomas of follicles: Mantle cell and follicular center cell lymphomas. Am. J. Clin. Pathol. 1993; 99: 409-420.
71. Shivdasani RA, Hess JL, Skarin AT, Pinkus GS. Intermediate lymphocytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J. Clin. Oncol. 1993; 11: 802-811.
72. Ott MM, Ott G, Kuse P et al. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 1994; 23: 329-334.
73. H genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403-407.
74. Matolcsy A, Chadburn A, Knowles DM. de novo CD5-positive and Richter's syndrome-associated diffuse large B-cell lymphomas are genotypically distinct. Am. J. Pathol. 1995; 147: 207-216.
75. Hiddemann W, Longo DL, Coiffier B et al. Lymphoma classification: The gap between biology and clinical management is closing. Blood 1996; 88: 4085-4089.